ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
Get verified emails for ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company employees
About ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
|
|
|
201-500 employees
View all
|
|
Biotechnology
|
|
US
|
|
ImClone Systems is a fully integrated global biopharmaceutical company committed to advancing oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers.
On November 24, 2008, ImClone Systems became a wholly-owned subsidiary of Eli Lilly and Company (NYSE: LLY).
|
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company Alternatives
Frequently Asked Questions about ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
Who is the CEO of ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company?
Wu Chen Jia is the CEO of ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company.
Who are the decision makers in ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company?
The decision makers in ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company are Alex Pie, Chuck Mellyn, Greg Reynolds, etc. Click to Find ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company decision makers emails.
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company Staff Directory
Search ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Search Portal
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
